GW29-e1538 Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program — Changsheng Ma (2018) | RDL Network
GW29-e1538 Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program
Sérgio Dubner, José Francisco Kerr Saraiva, Juan Carlos Núñez Fragoso, Gonzalo Barón‐Esquivias, Christine Teutsch, Venkatesh Kumar Gurusamy, Sabrina Marler, Menno V. Huisman, Professor Gregory Lip, Cecilia Zeballos
Professor Gregory Lip, Jonathan L. Halperin, Lionel Riou França, Kristina Zint, Miney Paquette, Shihai Lu, Kenneth J. Rothman, Christian D Adams S, Sérgio Dubner, Menno V. Huisman, Christine Teutsch, HC Diener
Michał Mazurek, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Changsheng Ma, Kenneth J. Rothman, Miney Paquette, Kristina Zint, Lionel Riou França, Shihai Lu, Dorothee B. Bartels, Menno V. Huisman, Professor Gregory Lip
Miney Paquette, Lionel Riou França, Christine Teutsch, Hans‐Christoph Diener, Shihai Lu, Sérgio Dubner, Chang Sheng, Kenneth J. Rothman, Kristina Zint, Jonathan L. Halperin, Brian Olshansky, Menno V. Huisman, Professor Gregory Lip, Robby Nieuwlaat
Sérgio Dubner, Menno V. Huisman, Hans‐Christoph Diener, Jonathan L. Halperin, Kenneth J. Rothman, Sara Bozzinì, Jutta Bergler‐Klein, Kristina Zint, Lionel Riou França, Shihai Lu, Christine Teutsch, Miney Paquette, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.